ProShare Advisors’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.06M | Sell |
10,138
-32
| -0.3% | -$3.34K | ﹤0.01% | 800 |
|
|
2025
Q1 | $1.19M | Sell |
10,170
-2,494
| -20% | -$291K | ﹤0.01% | 772 |
|
|
2024
Q4 | $1.07M | Buy |
12,664
+2,942
| +30% | +$249K | ﹤0.01% | 880 |
|
|
2024
Q3 | $874K | Buy |
9,722
+2,015
| +26% | +$181K | ﹤0.01% | 853 |
|
|
2024
Q2 | $620K | Sell |
7,707
-2,017
| -21% | -$162K | ﹤0.01% | 871 |
|
|
2024
Q1 | $776K | Buy |
9,724
+800
| +9% | +$63.8K | ﹤0.01% | 869 |
|
|
2023
Q4 | $710K | Buy |
8,924
+1,268
| +17% | +$101K | ﹤0.01% | 858 |
|
|
2023
Q3 | $535K | Buy |
7,656
+558
| +8% | +$39K | ﹤0.01% | 893 |
|
|
2023
Q2 | $510K | Buy |
7,098
+309
| +5% | +$22.2K | ﹤0.01% | 945 |
|
|
2023
Q1 | $419K | Sell |
6,789
-926
| -12% | -$57.1K | ﹤0.01% | 994 |
|
|
2022
Q4 | $595K | Buy |
7,715
+1,047
| +16% | +$80.8K | ﹤0.01% | 883 |
|
|
2022
Q3 | $297K | Buy |
6,668
+415
| +7% | +$18.5K | ﹤0.01% | 1160 |
|
|
2022
Q2 | $239K | Sell |
6,253
-2,865
| -31% | -$110K | ﹤0.01% | 1352 |
|
|
2022
Q1 | $378K | Sell |
9,118
-2,265
| -20% | -$93.9K | ﹤0.01% | 1476 |
|
|
2021
Q4 | $430K | Sell |
11,383
-225
| -2% | -$8.5K | ﹤0.01% | 1563 |
|
|
2021
Q3 | $383K | Sell |
11,608
-2,350
| -17% | -$77.5K | ﹤0.01% | 1374 |
|
|
2021
Q2 | $942K | Buy |
13,958
+1,386
| +11% | +$93.5K | ﹤0.01% | 1074 |
|
|
2021
Q1 | $712K | Buy |
12,572
+672
| +6% | +$38.1K | ﹤0.01% | 1206 |
|
|
2020
Q4 | $969K | Buy |
11,900
+2,498
| +27% | +$203K | ﹤0.01% | 898 |
|
|
2020
Q3 | $670K | Sell |
9,402
-291
| -3% | -$20.7K | ﹤0.01% | 834 |
|
|
2020
Q2 | $798K | Buy |
9,693
+3,365
| +53% | +$277K | ﹤0.01% | 777 |
|
|
2020
Q1 | $372K | Sell |
6,328
-4,545
| -42% | -$267K | ﹤0.01% | 810 |
|
|
2019
Q4 | $1.12M | Buy |
+10,873
| New | +$1.12M | 0.01% | 767 |
|